Opioid Substitution Therapy (OST) implicated deaths and prescribing: evidence review

This paper summarises current knowledge of trends around methadone and buprenorphine related deaths and changes to prescribing practice in Scotland.


An errata was published on Thursday 17th March 2022 as a result of changes on PDF page 7 to the figure for gabapentinoids implicated in methadone-implicated deaths, and to the percentage increase of buprenorphine-implicated deaths since 2019.

The HTML and PDF have been updated to reflect these changes.


Email: socialresearch@gov.scot

Back to top